In patients with tuberous sclerosis complex suffering from severe and treatment-resistant epilepsy, the mTOR pathway is hyperactivated due to mutations in TSC1 and TSC2 genes (Overwater et al., 2019). Here, TSC1 is linked to epilepsy.